Mylan N.V. (MYL) Announces U.S. Launch of Tadalafil Tablets USP 20mg, First Generic for Eli Lilly's (LLY) Adcirca Tablets
Tweet Send to a Friend
Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the first ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
